Video Latest - ecancer

Advances in chronic lymphocytic leukaemia: Expert panel discussion

Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan

19 Jun 2014

Genetically modified T cells fight haematological cancer

Dr Roman Galetto - Cellectis Therapeutics, Paris, France

19 Jun 2014

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

6 Jun 2014

WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg

6 May 2014

Work and history of the Kidney Cancer Association

Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA

6 May 2014

Intratumour heterogeneity in renal and lung cancer

Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK

6 May 2014

High levels of mutated p53 indicate metastatic phenotype

Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA

5 May 2014

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France

1 May 2014

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

1 May 2014

Role of genomics in assessing risk, especially in ovarian cancer

Dr Thomas Sellers - Moffitt Cancer Center, Tampa, USA

1 May 2014

Targeted Anti-cancer Therapies (TAT) conference roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

22 Apr 2014

Toll like receptor 7 agonists for cancer immunotherapy

Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany

25 Mar 2014

Video